| abstract |
There is disclosed a method for inhibiting and / or alleviating the occurrence of diseases associated with reactive oxygen compounds, reactive nitrogen compounds, radicals and / or non-radicals in a subject, wherein a subject is administered a carotenoid structural analogue, either alone or in combination with a other carotenoid anal and or co-antioxidant formulation. The analogue or analogue combination is administered so that the individual's risk of diseases associated with reactive oxygen compounds, reactive nitrogen compounds, radicals and / or non-radicals can thereby be reduced. The analog or analog combination may be administered to an individual for inhibition and / or relief of ischemia-reperfusion injury. The analog or analog combination may be administered to an individual for inhibition and / or relief of liver disease. Analog or analog combination may be administered to a subject for cancer inhibition and / or relief. The analog or analog combination may be administered to an individual for inhibition and / or relief of cardiac arrhythmias and / or sudden cardiac death. The analogue or analog combination may be administered to an individual for inhibition and / or relief of any disease which results in the production of reactive oxygen compounds, reactive nitrogen compounds, radicals and / or non-radicals. A water-soluble and / or water-dispersible astaxanthin analog is particularly effective. Also disclosed are pharmaceutical compositions comprising structural carotenoid analogues, either alone or in combination. |